Ban on fetal bovine serum usage in food biotechnology

1. Introduction

Fetal bovine serum (FBS) is a biological substance obtained from the blood of bovine fetuses. It is widely used in biotechnology research because it contains growth factors, proteins, hormones, and other nutrients that support the growth and multiplication of animal cells in laboratory environments.

In food biotechnology, FBS has historically been used in research and development involving cultured meat, cellular agriculture, animal-cell cultivation, and other cell-based food production technologies. It provides nutrients that help animal cells survive and multiply outside the animal's body.

However, the use of FBS raises important ethical, environmental, food-safety, and animal-welfare concerns. Its collection involves obtaining blood from bovine fetuses, which raises questions about animal suffering and the treatment of pregnant animals. Additionally, FBS may present risks associated with biological contamination, inconsistent composition, and traceability.

Consequently, regulators, biotechnology companies, and animal-welfare organizations have increasingly explored alternatives, including serum-free culture media and plant-based growth supplements.

A complete legal prohibition on FBS in food biotechnology does not currently exist uniformly across all jurisdictions. Instead, regulatory approaches differ according to the intended use, production process, animal-welfare requirements, and food-safety standards.

2. Meaning and applications of fetal bovine serum

FBS is a complex biological mixture obtained from bovine fetal blood. It contains nutrients and biological components that support cellular growth in laboratory conditions.

Its major applications in food biotechnology include:

Cultured meat research: Supporting the development and multiplication of animal cells for cultivated meat production.

Cellular agriculture: Supporting research into animal-derived food products produced through cell-culture technologies.

Biotechnology research: Supporting laboratory studies involving animal cells.

Food innovation: Assisting research into alternative proteins and cell-based food production.

Despite its scientific usefulness, FBS creates regulatory challenges because its biological origin and collection process raise animal-welfare and food-safety concerns.

3. Legal and ethical reasons for restricting FBS usage

A. Animal welfare concerns

One of the principal arguments against FBS usage concerns animal welfare.

The collection of FBS involves obtaining blood from bovine fetuses after slaughter of pregnant cattle. The procedure raises ethical questions about fetal welfare, the conditions of collection, and the broader treatment of animals in industrial biotechnology.

Animal-welfare legislation seeks to prevent unnecessary suffering and promote humane treatment.

In India, the Prevention of Cruelty to Animals Act, 1960, provides the principal legislative framework for preventing unnecessary pain and suffering to animals.

Section 11 identifies various forms of cruelty to animals.

Although the Act does not establish a general prohibition on FBS use, its animal-welfare principles are relevant to evaluating the practices associated with biological material collection.

B. Food safety and contamination risks

FBS is biologically derived and may contain unwanted microorganisms, viruses, or other contaminants if collection, processing, and quality control are inadequate.

Its use in food-production systems therefore requires appropriate assessment of:

Biological contamination.

Viral safety.

Microbial quality.

Chemical residues.

Batch consistency.

Traceability of biological materials.

Regulatory authorities must ensure that biological substances used during food production do not compromise the safety of the final product.

C. Environmental sustainability

The production and supply of FBS depend on cattle farming and slaughterhouse operations.

The growing demand for FBS in cellular agriculture may raise concerns about resource consumption, supply-chain sustainability, and dependence on conventional animal agriculture.

Serum-free alternatives may reduce some of these concerns, although their environmental benefits must be assessed through appropriate lifecycle analysis.

D. Ethical concerns regarding cultivated meat

Cultivated meat is frequently presented as an alternative to conventional animal agriculture.

However, continued dependence on animal-derived FBS creates an ethical contradiction because the production process still relies on biological material obtained from animals.

This has encouraged research into animal-free culture media and recombinant growth factors.

4. International regulatory framework

Different jurisdictions regulate FBS and its use in food biotechnology through food-safety, animal-welfare, and novel-food frameworks.

A. European Union

The European Union regulates novel foods through Regulation (EU) 2015/2283.

Cultivated meat products may fall within the novel-food authorization framework depending on their characteristics and production methods.

Applicants must provide scientific evidence demonstrating that the proposed food is safe for consumption.

The European Food Safety Authority (EFSA) evaluates relevant scientific evidence, including the manufacturing process, biological materials, and potential safety risks.

The EU framework does not establish a blanket prohibition on FBS in all food biotechnology applications. However, FBS-related production methods may be examined during the safety assessment of a novel food.

B. United States

In the United States, the FDA and USDA have responsibilities relating to cultivated animal-cell food products.

The FDA oversees relevant premarket consultation concerning cell-culture processes, while the USDA Food Safety and Inspection Service has jurisdiction over applicable meat and poultry products, including inspection and labelling requirements.

The regulatory framework focuses on production safety, biological materials, manufacturing controls, and the safety of the final product.

There is no general federal prohibition on FBS use across all biotechnology research or food-development applications.

C. Singapore

Singapore has developed a regulatory framework for novel foods under the Singapore Food Agency (SFA).

Novel food applications require safety assessments addressing the production process, ingredients, manufacturing controls, and toxicological considerations.

Singapore's approval of cultivated chicken in 2020 was an important development in cellular agriculture regulation.

The approval demonstrated the importance of assessing cell-culture ingredients and production methods rather than relying solely on the conventional classification of food products.

5. Indian legal framework governing FBS usage

India does not currently have a specific nationwide statutory ban on the use of FBS in all food biotechnology applications.

However, several laws and regulatory frameworks are relevant.

A. Food Safety and Standards Act, 2006

The Food Safety and Standards Act, 2006, establishes the legal framework for food safety and regulation in India.

The Food Safety and Standards Authority of India (FSSAI) is responsible for regulating food standards and protecting consumer interests.

Important provisions include:

Section 16: Functions of the Food Authority.

Section 18: General principles governing food safety administration.

Section 22: Regulation of novel foods and other specified food categories.

Section 26: Responsibilities of food business operators.

Section 22 is particularly relevant because innovative cell-based food products may require regulatory examination before entering the Indian food market.

B. Prevention of Cruelty to Animals Act, 1960

The Act establishes protections against unnecessary animal suffering.

Its provisions are relevant to examining the ethical implications of collecting biological materials from animals and developing animal-free alternatives.

However, it should not be interpreted as creating an automatic statutory ban on every use of FBS.

C. Environment (Protection) Act, 1986

This legislation provides a framework for environmental protection and regulation of specified hazardous biological activities.

The Rules, 1989, concerning genetically engineered organisms and hazardous microorganisms may become relevant where food biotechnology research involves regulated genetically engineered biological materials.

D. Consumer Protection Act, 2019

The Consumer Protection Act protects consumers against unfair trade practices and misleading representations.

If food manufacturers make inaccurate claims about animal-free production, cruelty-free ingredients, or manufacturing methods, such representations may raise consumer-protection issues.

6. Alternatives to fetal bovine serum

The development of alternatives is an important part of reducing dependence on FBS.

A. Serum-free culture media

Serum-free media are specially formulated nutrient solutions that support cell growth without using animal serum.

They can provide greater consistency and improve control over production conditions.

B. Plant-based growth supplements

Plant-derived proteins and nutrients may support certain cell-culture applications.

Their suitability depends on the type of animal cells being cultivated and the required growth conditions.

C. Recombinant growth factors

Recombinant proteins are produced through biotechnology and can replace certain growth-promoting components traditionally obtained from FBS.

They offer improved consistency and can reduce dependence on animal-derived materials.

D. Chemically defined culture media

Chemically defined media contain specified ingredients in controlled concentrations.

They offer greater transparency, reproducibility, and traceability, which are important characteristics for commercial food production.

7. Relevant case laws and judicial decisions

There are no widely established reported Indian or international judgments specifically ordering a blanket ban on fetal bovine serum in food biotechnology. Nevertheless, several judicial decisions provide relevant principles concerning animal welfare, environmental protection, and food safety.

A. Animal Welfare Board of India v. A. Nagaraja (2014), Supreme Court of India

The Supreme Court examined the legality of traditional bull-taming practices under the Prevention of Cruelty to Animals Act, 1960.

The Court emphasized animal welfare, compassion, and the responsibility to prevent unnecessary pain and suffering.

It recognized the importance of interpreting animal-protection legislation in a manner that respects animal dignity and welfare.

Legal significance: The judgment provides an important ethical and legal foundation for examining FBS collection practices. It supports the development of animal-welfare-conscious alternatives in biotechnology.

B. Centre for Environmental Law, WWF-India v. Union of India (2013), Supreme Court of India

The Supreme Court considered issues relating to wildlife conservation and the protection of endangered species.

The decision emphasized ecological protection and the importance of preserving biodiversity.

Legal significance: Although not directly concerned with FBS, the judgment reinforces the importance of environmental responsibility in scientific and industrial activities. Biotechnology production methods should be assessed for their broader ecological consequences.

C. Vellore Citizens' Welfare Forum v. Union of India (1996), Supreme Court of India

The Supreme Court addressed environmental pollution caused by industrial activities and recognized the precautionary principle and polluter-pays principle.

The Court emphasized that industrial development must not compromise environmental protection.

Legal significance: This decision supports precautionary regulatory assessment of new food-production technologies, including cell-culture systems using biological materials.

D. S. Jagannath v. Union of India (1997), Supreme Court of India

The Supreme Court examined environmental damage caused by intensive shrimp aquaculture and addressed the importance of sustainable development.

The Court emphasized that economic activities must operate within environmental safeguards.

Legal significance: The judgment provides broader principles for evaluating the environmental sustainability of industrial food biotechnology and alternative protein production.

8. Regulatory challenges and recommendations

The regulation of FBS in food biotechnology presents several challenges.

Major challenges include:

Lack of uniform international standards governing serum use in cultivated meat.

Ethical disagreements concerning fetal animal welfare.

Difficulty ensuring consistent biological quality.

High research and manufacturing costs associated with serum-free alternatives.

Limited regulatory guidance for emerging cellular agriculture technologies.

Challenges in verifying animal-free and cruelty-free production claims.

To address these concerns, governments and regulatory authorities should consider developing specific standards for biological ingredients used in food biotechnology.

Such standards should include:

Transparent disclosure of animal-derived culture ingredients.

Independent food-safety assessment.

Appropriate biological traceability.

Animal-welfare safeguards.

Encouragement of serum-free and chemically defined media.

Clear labelling requirements where legally appropriate.

Regular evaluation of alternative culture technologies.

9. Conclusion

The debate surrounding fetal bovine serum usage in food biotechnology reflects the growing need to balance scientific innovation, animal welfare, food safety, and environmental sustainability.

Although FBS has played an important role in cell-culture research, its animal origin and associated ethical and biological concerns have encouraged the development of serum-free and animal-free alternatives.

In India, the Food Safety and Standards Act, 2006, the Prevention of Cruelty to Animals Act, 1960, and the Environment (Protection) Act, 1986, provide relevant legal foundations for regulating these activities. However, none of these laws currently establishes a blanket prohibition on all FBS usage in food biotechnology.

The principles established in Animal Welfare Board of India v. A. Nagaraja, Vellore Citizens' Welfare Forum v. Union of India, and S. Jagannath v. Union of India support animal welfare, precautionary regulation, and environmental responsibility.

Ultimately, a dedicated regulatory framework encouraging animal-free culture media, transparent production practices, scientific safety assessment, and ethical biotechnology development would help create a more sustainable and responsible food biotechnology industry.